Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Mount Sinai Introduces the Marilyn Monroe Mental Health Initiative for Arts Professionals
Mount Sinai Health System has launched the Marilyn Monroe Mental Health for the Arts Program, a $100,000 initiative aimed at the unique psychological challenges of performing artists. Housed in the Samuel J. Friedman Health Center in New York’s theater district, the program combines Mount Sinai’s clinical expertise with the Entertainment Community Fund’s social‑service network. Led by Dr. Shilpa R. Taufique and psychiatrist Dr. Nicholas Kopple‑Perry, it offers onsite consultations, emergency care, and training for social‑work staff. The effort honors Monroe’s centennial and sets a template for arts‑focused mental‑health care.
4 Types of Drugs that May Increase Your Dementia Risk
A recent analysis highlights four medication classes—anticholinergic antihistamines, antipsychotics, benzodiazepines, and proton‑pump inhibitors (PPIs)—that may elevate dementia risk, especially with chronic use. Observational studies suggest antihistamines could increase risk by roughly 50%, while antipsychotics and benzodiazepines show mixed but concerning...
Innovative Nanoparticle Technique Advances Early Detection of Pancreatic Cancer
Researchers have unveiled a novel nanoparticle‑based imaging agent that markedly improves early detection of pancreatic cancer. In pre‑clinical trials the probe identified tumors as small as 2 mm, delivering a 30% sensitivity boost over conventional CT scans. The technology earned FDA...
Ensign CEO: Nursing Home Demand Is Strong Despite Fluctuating Volume, Payer Scrutiny
Ensign Group reported record occupancy and an 18.4% year‑over‑year revenue jump to $1.33 billion in Q1, underscoring strong demand for skilled nursing despite fluctuating patient volumes and heightened payer scrutiny. The company highlighted robust growth in managed‑care and Medicare censuses, up...
Oura Unveils Menopause Insights, Birth Control Tools, US Open Partnership
Oura introduced two new hormonal health features for its Ring: a birth‑control support tool embedded in the Cycle Insights suite and a Menopause Insights module that uses a proprietary questionnaire and biometric data to assess symptoms. The company also sealed...
Confluent Medical Technologies Hires New Chief Operating Officer
Confluent Medical Technologies announced the appointment of Tom Testa as chief operating officer, effective April 29. Testa brings a track record that includes serving as CEO and CFO of Corza Medical and as VP and general manager of Nordson Medical’s...
OIG Report: 73% of Nursing Homes Face Emergency Power Failures, Many Lack Backup Systems
An Office of the Inspector General audit found that 73 percent of the United States’ more than 15,000 nursing homes operate with inadequate or unreliable emergency power. The review of 100 Medicare‑ and Medicaid‑certified facilities uncovered 119 deficiencies, including 40...
Man Dies Covered in Necrotic Lesions After Amoebas Eat Him Alive
A 78‑year‑old man developed widespread necrotic skin lesions that were ultimately traced to a disseminated infection by the free‑living amoeba Acanthamoeba. The pathogen likely entered through nasal rinsing with tap water, a route rarely linked to full‑body disease in patients...
Validated Quality Signals Will Drive Digital Health Adoption
The Digital Medicine Society’s DiMe Seal and the CARIN Code of Conduct are being adopted by CMS to highlight high‑quality digital health apps for Medicare beneficiaries. By attaching these validated quality signals to apps, CMS can surface trustworthy solutions amid...
The Biopharm Brief: Microbiome Fast Track, Leo Pharma Gene Therapy Deal, AAV Automation Advances
The FDA has awarded Fast Track designation to a live biotherapeutic aimed at restoring gut microbiota in moderate‑to‑severe ulcerative colitis, accelerating its development path. Leo Pharma is buying Replay’s gene‑therapy program to broaden its rare‑dermatology portfolio, marking a shift toward...
DiMe and CARIN Alliance Helping Apps Get Into the Medicare App Library
DiMe (Digital Medicine Society) and the CARIN Alliance are collaborating with the Centers for Medicare & Medicaid Services (CMS) to define security and trust standards for apps seeking inclusion in the Medicare app library. The partnership aims to create a...
5th Circuit Panel Blocks 2023 Mifepristone Telemedicine Approval
The Fifth Circuit Court of Appeals issued a stay that blocks the FDA's 2023 rule allowing mifepristone to be prescribed via telemedicine. The stay reinstates the requirement that patients receive an in‑person medical evaluation before receiving the abortion pill. Louisiana,...
Trividia Health Correction for TRUE METRIX Blood Glucose Monitoring Systems
Trividia Health issued a follow‑up correction on May 1, 2026 for all TRUE METRIX blood‑glucose meters, updating labeling to clarify the E‑5 error code. The company is distributing new product notices to pharmacies, distributors and end users, and urges patients at high risk...
Stroke Prevention Devices for TAVR Fail to Make an Impact
A new meta‑analysis of eight randomized trials involving more than 11,000 transcatheter aortic valve replacement (TAVR) patients found that cerebral embolic protection devices (CEPDs) did not significantly lower overall, disabling, or non‑disabling stroke rates. Roughly half of the participants received...
High Contrast, Low Risk: Black Marking for Medical Technology
Ultrashort‑pulse laser black marking has become a viable solution for UDI compliance on medical‑grade stainless steel, delivering permanent, high‑contrast codes despite polished surfaces and tiny marking areas. FOBA’s F.0100‑ir system creates nanostructured “light traps” that produce matte black marks with...
E-Scopics Announces New FDA Clearance for Hepatoscope® With Expanded Capabilities in Managing Liver Disease Complications, Advanced Elastography Imaging Features, and...
E‑Scopics announced FDA clearance for enhancements to its Hepatoscope® platform, adding a dedicated spleen exam workflow and upgraded 2D transient elastography (2DTE) that complies with IEC 63412‑1. The device now runs on macOS laptops with Apple M3 chips and integrates HL7 FHIR R4...
DOJ Forms Health Care Fraud Strike Force
The U.S. Department of Justice has launched the West Coast Health Care Fraud Strike Force, a multi‑district initiative that brings together the DOJ’s Health Care Fraud Section, the U.S. Attorney’s Offices in Arizona, Nevada and Northern California, the FBI, the...
Artificial Intelligence for Drug Development
The FDA’s Center for Drug Evaluation and Research (CDER) is formalizing its AI strategy through a draft 2025 guidance, an AI Council created in 2024, and extensive stakeholder engagement. CDER has reviewed more than 500 AI‑enabled drug submissions since 2016...
External Engagements with FDA for Artificial Intelligence in Drug Development
The FDA has published a comprehensive menu of early‑engagement options for sponsors leveraging artificial intelligence across the drug development lifecycle. Sponsors can request formal meetings for IND or pre‑IND programs, or use targeted programs such as C3TI for trial design,...
Zhejiang Huahai Pharma Posts Q1 Net Profit Rise to $62 M on Robust Generic Sales
Zhejiang Huahai Pharmaceutical Co., Ltd. announced Q1 net profit of RMB444.33 million ($62 million), up from RMB375.01 million a year earlier, driven by strong generic drug sales. Revenue slipped 1.4% to RMB2.335 billion ($327 million), highlighting a shift toward higher‑margin products amid a tightening Chinese...
San Francisco Dental Implant Center Unveils New Educational Series on Smile Improvement
San Francisco Dental Implant Center announced the launch of a new educational blog series that explains how modern dental implants can improve smiles and reduce social anxiety. The content, authored by oral surgeon Dr. Alex Rabinovich, highlights titanium implant technology,...
Katherine Szarama, PhD, Named Acting CBER Director: Who’s Next?
Vinay Prasad stepped down as director of the FDA's Center for Biologics Evaluation and Research (CBER), and Katherine Szarama, PhD, was named acting director. Szarama, a biologist with prior experience as CBER deputy director and stints at CMS, Emerson Collective...
Eli Lilly Q1 2026 EPS $8.55 Beats Forecast, Revenue $19.8B Tops Estimates
Eli Lilly reported first‑quarter 2026 earnings of $8.55 per share and $19.8 billion in revenue, outpacing analyst forecasts by 22.7% and 12.5% respectively. The beat lifted the stock 5.96% in pre‑market trade and prompted an upward revision of full‑year revenue guidance...
Teleflex Names Jason Weidman CEO, Launches $1 B Buyback, $800 M Debt Cut
Teleflex announced Jason Weidman as its new president and CEO and outlined a $1 billion share‑buyback and $800 million debt‑paydown strategy. The move signals a leadership shift aimed at accelerating growth in interventional and critical‑care markets while reshaping the balance sheet.
US and UK Disability Policy Shifts Heighten HR Compliance Risks
Recent U.S. and U.K. policy moves—from Nebraska’s Medicaid work‑requirement rollout to the U.K.’s “Right to Try” legislation—are reshaping benefits for disabled adults. The changes force HR leaders to reassess accommodation, benefits administration, and compliance with ADA and related statutes.
Regulatory and IP Considerations for Veterinary Drugs in Canada
The article outlines Canada’s regulatory framework for veterinary drugs, separating them from other animal health products and detailing the data‑protection, patent‑linkage, and supplementary‑protection regimes that apply only to veterinary drugs. It explains submission requirements, labeling rules, priority‑review criteria, and biowaiver...
Durham‑Jagiellonian Team Unveils DNA Nano‑Rings to Capture Viral Membrane Proteins
Scientists from Durham University and Poland's Jagiellonian University have created DNA‑origami nano‑rings that capture and precisely orient viral membrane proteins. The platform, called DNA‑Origami‑Constrained Nanodiscs (DOC‑NDs), promises higher‑resolution imaging and new antiviral strategies.
Arvinas’ ‘Protac’ Breast Cancer Drug Cleared by FDA
The FDA approved Arvinas and Pfizer’s Veppanu, a PROTAC drug, as a second‑line therapy for metastatic ER‑positive, HER2‑negative breast cancer with ESR1 mutations. Veppanu is the first protein‑degrading medicine cleared in the U.S., targeting estrogen receptors for destruction. While the...
Techcyte Raises $15M to Expand AI Diagnostics Platform
Techcyte closed a $15 million funding round led by Van Tuyl Companies to scale its AI‑powered Fusion platform. The round brings strategic partners such as Zoetis and the Mayo Clinic, granting access to a 17 million‑slide dataset. Fusion integrates anatomic and clinical pathology,...
UniQure Pushes Forward As FDA Rare Disease Controversies Continue
UniQure, the gene‑therapy pioneer at the heart of FDA Commissioner Marty Makary’s rare‑disease controversy, is pressing forward with a formal request for its Huntington’s disease treatment. The company will present data at a Type B meeting with the FDA in the...
RFK Jr. Wants Stakeholders To Show Real-Time Prices Ahead Of Final Regulation
HHS Secretary Robert F. Kennedy Jr. is urging health‑care providers and health‑IT firms to deploy Real‑Time Pharmacy Benefit Technology (RTPBT) immediately, rather than waiting for formal rulemaking. RTPBT enables patients to see the exact out‑of‑pocket cost of prescription drugs at...
The World Wants to Eliminate Cervical Cancer - How Australian Scientists Led the Way
Australian scientists pioneered the Gardasil HPV vaccine, enabling the world’s first national vaccination programme in 2007 and positioning Australia to eliminate cervical cancer by 2035. The combined strategy of >80% vaccination of adolescents, HPV‑based screening every five years, and self‑sampling...
South Carolina Measles Outbreak Declared over; Utah Reaches 625 Cases
South Carolina’s measles outbreak, which infected 997 people, was declared over after a 42‑day stretch with no new cases, meeting the CDC’s containment threshold on April 26. During the crisis, statewide MMR vaccinations jumped 31.1% and Spartanburg County saw a 93.6%...
DNA-Containing Extracellular Vesicles Boost Antitumor Responses in Mice
Researchers at Weill Cornell Medicine discovered that extracellular vesicles released by activated T cells contain DNA that can be transferred to dendritic and tumor cells, enhancing antigen processing and presentation. In mouse models of glioblastoma, pancreatic and triple‑negative breast cancer,...
Rare Fatal Arrhythmias After PFA Highlighted in MAUDE Analysis
The TiFFANY analysis of FDA MAUDE reports identified fatal arrhythmic events after pulsed‑field ablation (PFA) for atrial fibrillation at roughly 3.2 per 100,000 procedures, translating to a mortality rate of 17.8 per 100,000—about twice that of thermal ablation. Overall, PFA showed a...
Advocates Sound Alarm Over Nebraska Starting Medicaid Work Reqs
Nebraska began enforcing the One Big Beautiful Bill Act’s Medicaid work requirements on May 1, earlier than many states. Advocates warn that the rollout suffers from insufficiently trained staff, an incomplete exemption list, and confusing outreach to beneficiaries. The state’s hurried...
Noninvasive Proton Beam Therapy Safe for VT Ablation: Early Series
A first‑in‑human feasibility study at Mayo Clinic showed that noninvasive proton‑beam radioablation can be delivered safely to patients with refractory ventricular tachycardia (VT). Seven high‑risk patients underwent meticulous imaging‑guided planning and received a single proton dose, with no acute cardiac...
Obamacare Enrollment Drops Sharply as Costs Rise
Enrollment in the Affordable Care Act marketplaces has plunged sharply after Congress let the enhanced subsidies lapse at the end of 2025. Industry analysts estimate a 20% drop, taking coverage from roughly 24 million to about 19 million, with some forecasts suggesting...
Why, if After 7 to 21 Years of Follow-Up Data, Disc Arthroplasty Has a Mere 0.67% Index Level Revision Rate,...
A large real‑world cohort of 1,187 lumbar total disc arthroplasty patients was followed for 7 to 21 years, revealing an index‑level revision rate of just 0.67% and an adjacent‑level surgery rate of 1.85%. Clinical outcomes—Oswestry Disability Index and VAS pain...
Why Nursing Home Regulations Must Address Mental Illness
Nursing homes are increasingly serving as de‑facto psychiatric wards, with residents facing depression, bipolar disorder, schizophrenia and dementia. A study projects the resident population will triple by 2050, while staffing levels remain far below the 4.1 hours per resident per day...
Allosteric Switch in TB Enzyme Opens New Drug Target
A newly identified allosteric switch in the ICL2 enzyme of Mycobacterium tuberculosis reveals a potential pathway for targeting drug-resistant TB, offering insight into protein regulation unique to the bacterium. structuralbiology
OTC Hearing Aids Offer Affordable, Game‑changing Solution
More hearing aids? Yes, because lots of folks have mild hearing loss, and OTC solutions are affordable and, honestly, game changing. This time I'm looking at the new Techmi FacePro OTC Hearing Aids in this demo and review: https://t.co/W0GUOshnHY #hearing...
The Next Alzheimer’s Breakthrough Will Take More Than Just Science
Alzheimer’s research has moved from theory to treatment as anti‑amyloid antibodies like Lecanemab and Donanemab receive regulatory approval and begin reaching patients. These drugs can clear existing amyloid plaques and modestly slow cognitive decline, extending the disease trajectory from roughly...
Vaccination Quickly Halts Measles Outbreak After Decline
A play in 4 parts: 1. Measles vax rates drop below 90% 2. Measles outbreak infects 1,000 3. 20,000 measles vaccines given 4. No new cases; outbreak over "Measles vaccinations [were] the most effective single containment tool” https://t.co/rE8lSQ45VF
Employers Can Bridge GLP‑1 Coverage Gaps with Integrated Care
GLP‑1s are changing lives. Coverage realities have not caught up. GLP‑1 Flex Care at @OmadaHealth gives employers a way to pair cash‑pay GLP‑1 access with clinical evaluation, medical oversight, and behavior change on one platform — so support does not disappear...
OracleHealth Backs Standardized Prior Authorizations to Cut Costs
The @OracleHealth team proudly supports efforts to establish a more consistent, standardized approach to prior authorization. With this initiative, we can help reduce complexity, lower administrative costs, and better meet patient needs. https://t.co/XI1SKbNmQU
Questioning High Drug Prices and Transparency of New Tech
Oh okay. Just like TrumpRx, which charges patients more for many common drugs. Let’s see some data on how well this technology works and how transparent it really is.
HDL Inflammatory Markers Predict Mortality in Elderly
High-density lipoprotein-related inflammatory markers and their association with all-cause and cardiovascular mortality in an ageing population: findings from a prospective cohort study based on NHANES data https://t.co/WdNtpIgGpI https://t.co/cM0LeTv7io
Don't Let One Hero Eclipse Other Scientific Pioneers
Beware the lure of the romantic main character. Jim Allison is awesome. But don't forget Tasuku Honjo. https://t.co/C4hUtqv7uW
Clean Data Drives Success in Healthcare M&A
1 in 5 healthcare orgs went through M&A between 2015 and 2020. But success depends on more than cost-cutting—it depends on clean, accessible data. See how Harmony Healthcare IT can help: https://t.co/qJlZ72g01S @HarmonyHIT #ViVE2026 #HITSM